Precigen (PGEN) Long-Term Debt Issuances (2013 - 2025)

Precigen (PGEN) posted quarterly Long-Term Debt Issuances of -$654000.0 for Q4 2025, down 273.94% quarter-over-quarter from $376000.0 in Q1 2019.

Analysis

Precigen (PGEN) Long-Term Debt Issuances (2013 - 2025) Analysis & Trends

Precigen (PGEN) has reported Long-Term Debt Issuances for 8 consecutive years, with -$654000.0 the latest figure, recorded in Q4 2025.

In Q4 2025, Long-Term Debt Issuances changed N/A year-over-year to -$654000.0; the TTM figure through Dec 2025 stood at -$654000.0 (changed N/A YoY), while the FY2025 annual figure was $92.8 million, changed N/A from the prior year.
Long-Term Debt Issuances declined to -$654000.0 in Q4 2025 per PGEN's latest filing, from $376000.0 in the prior quarter.
Across five years, Long-Term Debt Issuances topped out at -$654000.0 in Q4 2025 and bottomed at -$654000.0 in Q4 2025.

Peer Set

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Long-Term Debt Issuances (Qtr)
1	Vertex Pharmaceuticals	138.47 Bn	130.62 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	85.18 Bn	77.19 Bn	3.93 Bn	-
3	Argenx Se	63.38 Bn	58.19 Bn	1.37 Bn	-
4	Moderna	58.09 Bn	52.95 Bn	52.00 Mn	-
5	Revolution Medicines	44.33 Bn	44.33 Bn	-	-
6	BeOne Medicines	40.02 Bn	34.92 Bn	1.53 Bn	-
7	Alnylam Pharmaceuticals	35.57 Bn	32.27 Bn	992.69 Mn	-
8	Royalty Pharma	28.45 Bn	27.61 Bn	-	-
9	Insmed	27.48 Bn	26.32 Bn	358.27 Mn	-
10	Precigen	2.53 Bn	2.53 Bn	52.17 Mn	-

Historic Data

Download Data